Campbell Fund Trust Reports Unregistered Equity Sales
| Field | Detail |
|---|---|
| Company | Campbell Fund Trust |
| Form Type | 8-K |
| Filed Date | Nov 6, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2,944,000, $2,144,019.60, $100,000.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-securities, equity-sale
TL;DR
Campbell Fund Trust sold unregistered equity, details TBD.
AI Summary
On October 31, 2025, Campbell Fund Trust reported unregistered sales of equity securities. The filing does not specify the exact amount of securities sold or the proceeds received, but it indicates a transaction occurred under the 'Unregistered Sales of Equity Securities' item.
Why It Matters
This filing indicates potential dilution or changes in ownership structure for Campbell Fund Trust, which could impact existing shareholders.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes indicate less transparency or potential regulatory scrutiny compared to registered offerings.
Key Players & Entities
- CAMPBELL FUND TRUST (company) — Registrant
- October 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Campbell & Company, LP (company) — Address of principal executive offices
- Baltimore, Maryland (location) — Address of principal executive offices
FAQ
What specific type of equity security was sold?
The filing does not specify the exact type of equity security sold, only that it falls under 'Unregistered Sales of Equity Securities'.
What was the total dollar amount of the unregistered equity securities sold?
The filing does not disclose the specific dollar amount of the unregistered equity securities sold.
Were these sales made to accredited investors?
The filing does not provide details on the nature of the purchasers, only that the sales were unregistered.
What is the purpose of these unregistered sales?
The filing does not state the purpose behind the unregistered sales of equity securities.
Are there any ongoing legal or regulatory implications associated with these unregistered sales?
The filing does not mention any specific ongoing legal or regulatory implications related to these unregistered sales.
Filing Stats: 462 words · 2 min read · ~2 pages · Grade level 14.4 · Accepted 2025-11-06 14:06:46
Key Financial Figures
- $2,944,000 — interest, sold on October 31, 2025 was $2,944,000.00, $2,144,019.60 and $100,000.00 in ca
- $2,144,019.60 — on October 31, 2025 was $2,944,000.00, $2,144,019.60 and $100,000.00 in cash for Series A, S
- $100,000.00 — 25 was $2,944,000.00, $2,144,019.60 and $100,000.00 in cash for Series A, Series D and Seri
Filing Documents
- ef20058469_8k.htm (8-K) — 28KB
- 0001140361-25-040738.txt ( ) — 140KB
- cft-20251031.xsd (EX-101.SCH) — 4KB
- cft-20251031_lab.xml (EX-101.LAB) — 20KB
- cft-20251031_pre.xml (EX-101.PRE) — 14KB
- ef20058469_8k_htm.xml (XML) — 4KB
02
Item 3.02 Effective as of October 31, 2025, Registrant sold equity securities in Registrant ("Units of Beneficial Interest") to existing and/or new unitholders of Registrant in transactions that were not registered under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate estimate consideration for Units of Beneficial Interest, excluding escrow interest, sold on October 31, 2025 was $2,944,000.00, $2,144,019.60 and $100,000.00 in cash for Series A, Series D and Series W, respectively. The Units of Beneficial Interest were issued by Registrant in reliance upon an exemption from registration under the Securities Act set forth in Section 4(2) of the Securities Act, as transactions not constituting a public offering of securities because the Units of Beneficial Interest were issued privately pursuant to Regulation D.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CAMPBELL FUND TRUST Date: November 6, 2025 By: /s/ Thomas P. Lloyd Thomas P. Lloyd General Counsel and Chief Compliance Officer